Blog
RSS FeedPosted by Michael Wonder on 09 Dec 2020
COVID-19 vaccine trial deaths were not related to treatment: Pfizer
9 December 2020 - Two people who received Pfizer’s experimental COVID-19 vaccine died during clinical trials, but the pharma giant says ...
Posted by Michael Wonder on 09 Dec 2020
Blunders eroded U.S. confidence in early vaccine front-runner
8 December 2020 - The Oxford-AstraZeneca effort held great promise to help arrest the pandemic. But a series of miscues caused ...
Posted by Michael Wonder on 08 Dec 2020
Trump Administration passed on chance to secure more of Pfizer vaccine
7 December 2020 - The pharmaceutical company offered the government a chance to lock in additional supplies before its vaccine was ...
Posted by Michael Wonder on 08 Dec 2020
Pfizer's vaccine offers COVID-19 protection after first dose, FDA says
9 December 2020 - Pfizer has cleared the next hurdle in the race to get its COVID-19 vaccine approved for ...
Posted by Michael Wonder on 07 Dec 2020
FDA could authorise Pfizer’s COVID-19 vaccine this week as U.S. deaths surge
7 December 2020 - An FDA advisory group is scheduled to convene on Thursday to review Pfizer’s vaccine. ...
Posted by Michael Wonder on 06 Dec 2020
The elderly vs. essential workers: who should get the coronavirus vaccine first?
5 December 2020 - The C.D.C. will soon decide which group to recommend next, and the debate over the trade-offs is ...
Posted by Michael Wonder on 06 Dec 2020
HHS’s Alex Azar says Pfizer vaccine could receive green light within days
6 December 2020 - The top U.S. health official said the federal government could authorise Pfizer’s COVID-19 vaccine within days ...
Posted by Michael Wonder on 05 Dec 2020
Pfizer slashes its original COVID-19 vaccine rollout target after supply-chain obstacles
4 December 2020 - Pfizer expects to ship half of the COVID-19 vaccines it originally planned for this year because ...
Posted by Michael Wonder on 03 Dec 2020
Lilly announces 650,000 additional doses of neutralising antibody bamlanivimab (LY-CoV555) purchased by U.S. government to treat COVID-19
2 December 2020 - The U.S. government has purchased 650,000 additional doses of Eli Lilly and Company's neutralising antibody bamlanivimab (LY-CoV555) ...
Posted by Michael Wonder on 03 Dec 2020
FDA grant fast track designation for remestemcel-L in the treatment of acute respiratory distress syndrome due to COVID-19
2 December 2020 - Mesoblast today announced that the United States FDA has granted fast track designation for remestemcel-L in the ...
Posted by Michael Wonder on 03 Dec 2020
Pushed to rush, FDA head says feds will get vaccine 'right'
2 December 2020 - The head of the agency responsible for authorising COVID-19 vaccines says it will take the time needed ...
Posted by Michael Wonder on 02 Dec 2020
Trump to meet next week with industry, government officials on COVID vaccine
2 December 2020 - President Donald Trump will gather leaders from industry and government next week for a summit on the ...
Posted by Michael Wonder on 01 Dec 2020
US hopeful of pre-Christmas COVID jab, Australia still has long wait
1 December 2020 - Millions of vulnerable Americans could be vaccinated against coronavirus before the end of 2020 but it ...
Posted by Michael Wonder on 30 Nov 2020
Moderna submits vaccine for FDA regulatory approval
30 November 2020 - Recent vaccine developments have been met with optimism among scientists and stock markets, but experts also urge ...
Posted by Michael Wonder on 30 Nov 2020
Pharmacies add freezers, train staff to handle COVID-19 vaccination drive
29 November 2020 - Many supermarkets have offered customers flu shots for years, but COVID-19 vaccine distribution will require more coordination ...